Chunxiang Li Selected Research

Liver Cirrhosis (Hepatic Cirrhosis)

12/2019

Interleukin-9 blockage reduces early hepatic granuloma formation and fibrosis during Schistosoma japonicum infection in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunxiang Li Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 04/2011
7	Body Remains 11/2021 - 01/2009
5	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2014
4	Adenocarcinoma of Lung 01/2022 - 12/2020
4	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2013
3	Inflammation (Inflammations) 09/2022 - 06/2017
3	Carcinogenesis 01/2022 - 10/2015
3	Rectal Neoplasms (Rectal Cancer) 01/2021 - 01/2020
3	Infections 10/2019 - 06/2010
2	Esophageal Squamous Cell Carcinoma 01/2022 - 01/2020
2	Congenital Heart Defects (Congenital Heart Defect) 10/2021 - 01/2019
2	Granuloma 12/2019 - 06/2017
2	Schistosomiasis (Bilharziasis) 12/2019 - 06/2017
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 02/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 06/2011 - 01/2010
1	Tuberculosis (Tuberculoses) 04/2022
1	Obesity 01/2022
1	Acute Lung Injury 12/2021
1	Dental Calculus 11/2021
1	Pneumonia (Pneumonitis) 05/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Heart Failure 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2021
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Fibrosis (Cirrhosis) 12/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2019
1	Chronic Hepatitis B 12/2019
1	Schistosomiasis japonica 12/2019
1	Ventilator-Associated Pneumonia 01/2019
1	Klatskin Tumor 01/2017
1	Cholangiocarcinoma 01/2017
1	Coronary Stenosis (Coronary Artery Stenosis) 09/2016
1	Communicable Diseases (Infectious Diseases) 04/2014

Drug/Important Bio-Agent (IBA)

5	Biological ProductsIBA 01/2022 - 06/2010
4	Long Noncoding RNAIBA 01/2022 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 07/2018
4	Ancient DNAIBA 11/2021 - 01/2009
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2014
3	Mitochondrial DNA (mtDNA)IBA 07/2015 - 02/2010
2	Pharmaceutical PreparationsIBA 04/2022 - 10/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2015
2	ChemokinesIBA 01/2022 - 12/2021
2	CytokinesIBA 01/2021 - 12/2019
2	Immune Checkpoint InhibitorsIBA 01/2021 - 12/2020
2	Interleukin-9 (Interleukin 9)IBA 12/2019 - 06/2017
2	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 02/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2011
1	PPAR gammaIBA 09/2022
1	Particulate MatterIBA 09/2022
1	Pyrazinamide FDA LinkGeneric 04/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 04/2022
1	Ethambutol (Myambutol)FDA LinkGeneric 04/2022
1	Interleukin-2 (IL2)IBA 04/2022
1	Isoniazid (Ftivazide)FDA LinkGeneric 04/2022
1	histone H3 trimethyl Lys4IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	InterferonsIBA 01/2022
1	Chemokine ReceptorsIBA 12/2021
1	HMGB1 Protein (HMG1)IBA 12/2021
1	LipopolysaccharidesIBA 12/2021
1	Milk Proteins (Milk Protein)IBA 11/2021
1	Histones (Histone)IBA 10/2021
1	MethyltransferasesIBA 10/2021
1	Carbon DioxideIBA 10/2021
1	InterleukinsIBA 05/2021
1	interleukin-21 (interleukin 21)IBA 05/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Competitive Endogenous RNAIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Circular RNAIBA 01/2021
1	LigandsIBA 01/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2021
1	Therapeutic UsesIBA 12/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2020
1	Clofazimine (Lamprene)FDA Link 01/2020
1	LeptinIBA 01/2020
1	AdipokinesIBA 01/2020
1	Leptin ReceptorsIBA 01/2020
1	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2019
1	CollagenIBA 12/2019
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2018
1	ApolipoproteinsIBA 01/2018
1	Hematoxylin (Haematoxylon)IBA 06/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2017
1	Aquaporin 1IBA 01/2017
1	CarbohydratesIBA 11/2014
1	MicroRNAs (MicroRNA)IBA 04/2014

Therapy/Procedure

6	Immunotherapy 01/2022 - 12/2020
2	Therapeutics 10/2021 - 12/2020
2	Neoadjuvant Therapy 01/2020 - 01/2020
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 10/2021
1	Radiotherapy 01/2021
1	Cardiac Resynchronization Therapy 01/2021
1	Photochemotherapy (Photodynamic Therapy) 12/2020
1	Drug Therapy (Chemotherapy) 01/2018
1	Percutaneous Coronary Intervention 09/2016